A patient in the high clinical risk group having a lesion with GS 4 + 5 = 9 (GGG 5) PCa with high (SUVmax 8.1) 18F-fluciclovine index tumor uptake demonstrated high ASCT2 and moderate LAT1 intensity (Fig. 5). The gene discussed is SLC1A5; the disease is neoplasm.